文献速递认知障碍与痴呆

阿尔茨海默病前20个风险变异与脑淀粉样变性的关联

Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.
PubMed 文献 · JAMA Neurol · 2018-01-01

该研究基于ADNI队列977名认知正常、轻度认知障碍和AD痴呆参与者的遗传与18F-florbetapir PET数据,分析前20个AD风险变异与脑淀粉样变性的关联。结果显示ABCA7与淀粉样沉积关联最强(除APOE ε4外),FERMT2呈现阶段依赖性关联,提示AD基因可能在不同疾病阶段差异调控病理。

要点

  • ABCA7是与脑淀粉样沉积关联最强的风险基因(除APOE ε4外)。
  • ABCA7在无症状和早期症状阶段均与淀粉样变相关,提示与快速淀粉样积聚有关。
  • FERMT2与脑淀粉样变呈阶段依赖性关联,在轻度认知障碍阶段最明显。

核心结论

  • 研究发现多个AD风险变异与脑淀粉样变性相关。
  • 数据提示AD基因可能在不同疾病阶段差异调控AD病理表现。

研究设计与样本

  • 分析ADNI前瞻性观察性多中心研究中977名参与者的遗传和18F-florbetapir PET数据。
  • 参与者包括322名认知正常对照、496名轻度认知障碍和159名AD痴呆个体。
  • 采用逐步多变量线性回归控制年龄、性别和APOE ε4基因型,并探索性使用SPM8三维逐步回归。

主要发现

  • ABCA7与淀粉样沉积关联最强(χ2=8.38,FDR校正P<.001),仅次于APOE ε4。
  • ABCA7在无症状和早期症状阶段均显示显著关联,提示与快速淀粉样积聚相关。
  • FERMT2与脑淀粉样变呈阶段依赖性关联(FERMT2×诊断χ2=3.53,FDR校正P=.05),在轻度认知障碍阶段最明显。

关键数值与推荐

  • 探索性体素分析采用簇和显著性阈值50体素及未校正P<.01。

临床怎么用

  • ABCA7和FERMT2等风险变异或有助于识别不同疾病阶段的淀粉样病理风险。
  • 遗传信息可能辅助分层AD不同临床阶段的病理机制研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Late-onset Alzheimer disease (AD) is highly heritable. Genome-wide association studies have identified more than 20 AD risk genes. The precise mechanism through which many of these genes are associated with AD remains unknown. OBJECTIVE: To investigate the association of the top 20 AD risk variants with brain amyloidosis. DESIGN, SETTING, AND PARTICIPANTS: This study analyzed the genetic and florbetapir F 18 data from 322 cognitively normal control individuals, 496 individuals with mild cognitive impairment, and 159 individuals with AD dementia who had genome-wide association studies and 18F-florbetapir positron emission tomographic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a prospective, observational, multisite tertiary center clinical and biomarker study. This ongoing study began in 2005. MAIN OUTCOMES AND MEASURES: The study tested the association of AD risk allele carrier status (exposure) with florbetapir mean standard uptake value ratio (outcome) using stepwise multivariable linear regression while controlling for age, sex, and apolipoprotein E ε4 genotype. The study also reports on an exploratory 3-dimensional stepwise regression model using an unbiased voxelwise approach in Statistical Parametric Mapping 8 with cluster and significance thresholds at 50 voxels and uncorrected P < .01. RESULTS: This study included 977 participants (mean [SD] age, 74 [7.5] years; 535 [54.8%] male and 442 [45.2%] female) from the ADNI-1, ADNI-2, and ADNI-Grand Opportunity. The adenosine triphosphate-binding cassette subfamily A member 7 (ABCA7) gene had the strongest association with amyloid deposition (χ2 = 8.38, false discovery rate-corrected P < .001), after apolioprotein E ε4. Significant associations were found between ABCA7 in the asymptomatic and early symptomatic disease stages, suggesting an association with rapid amyloid accumulation. The fermitin family homolog 2 (FERMT2) gene had a stage-dependent association with brain amyloidosis (FERMT2 × diagnosis χ2 = 3.53, false discovery rate-corrected P = .05), which was most pronounced in the mild cognitive impairment stage. CONCLUSIONS AND RELEVANCE: This study found an association of several AD risk variants with brain amyloidosis. The data also suggest that AD genes might differentially regulate AD pathologic findings across the disease stages.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Apostolova LG, Risacher SL, Duran T, et al. Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis. JAMA Neurol. 2018. PMID: 29340569. doi:10.1001/jamaneurol.2017.4198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。